The Draft Regulation of the Minister of Health amending the Regulation on guaranteed services in the field of hospital treatment has been submitted for consultation.
Innovative corneal treatment soon to be "on NFZ"
Published July 25, 2023 12:17
Fot. Thinkstock/Getty Images
The purpose of the proposed regulation on guaranteed inpatient services is to increase access to guaranteed services for patients diagnosed with corneal cone.
The introduction of the guaranteed benefit of corneal cone surgery by cross-linking to the Regulation of the Minister of Health of November 22, 2013 on guaranteed benefits in the field of hospital treatment was based on Recommendation No. 88/2022 of the President of the Agency for Health Technology Assessment and Tarification of September 30, 2022. The amendment under procedure is aimed at ensuring the availability of the benefit in question.
In the rationale for the recommendation, the President of the Agency for Health Technology Assessment and Tarification emphasizes that the results of research studies show that the intervention is effective in slowing the rate of disease progression. In a systematic review of the Kobashi 2017 RCT (PS), the CXL intervention compared to no treatment in the control arm showed statistically significantly better results for best visual acuity with spectacle correction. After 12 months of follow-up, the mean difference in corrected visual acuity values for CXL vs comparator was -0.09 logMAR. The results for this endpoint obtained in the identified RCTs are consistent with the conclusions of PS Kobashi 2017. A surrogate endpoint directly related to CXL is the measurement of corneal curvature (Kmax). The studies discussed in PS Kobashi 2017 showed an advantage for Kmax over no treatment for CXL. The results presented in each of the other RCTs included in the analysis also show a patient benefit.
Source: RCL
